|Day Low/High||17.28 / 17.74|
|52 Wk Low/High||9.85 / 20.02|
Teleconference Scheduled for August 7, 2017, at 5:00 p.m. ET
Investors considering a purchase of CytomX Therapeutics Inc shares, but tentative about paying the going market price of $13.51/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the November put at the $12.50 strike, which has a bid at the time of this writing of 95 cents.
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.
Stocks snap a holding pattern to pull lower on Monday afternoon as a crude oil slump weighS on the energy sector.
Biotech companies show more energy than the rest of the market Monday.
Stocks move mostly higher on Monday morning as a hearing on Russia's involvement in the U.S. election begins on Capitol Hill.
CytomX Therapeutics, Aevi Genomic Medicine and Esperion Therapeutics were among the biotech stock movers in premarket trading on Monday.
Shares of the biotech, which researches cancer drugs, were up nearly 30% ahead of market's open.
Stock futures move mostly lower on Monday after the weekend's G20 meeting raises fears over protectionist attitudes among the world's largest economies.
Teleconference Scheduled for Monday, March 20, 2017 at 8:00 a.m. ET
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.